Stocks to Watch: Serina Therapeutics, Powell Max, Silexion Therapeutics
Express News | Serina Therapeutics Inc - Transaction Eliminates $11.2 Million in Debt
Serina Therapeutics Announces Sale of UniverXome Subsidiary
Serina Therapeutics Appoints Karen J. Wilson to Board of Directors
Serina Therapeutics Names Karen Wilson to Its Bd of Directors
Express News | Serina Therapeutics Welcomes Karen J. Wilson to Its Board of Directors
Serina Therapeutics to Present at Tribe Public's Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024
Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit
Serina Therapeutics Shares Rise After $10 Million in Financing
Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket
Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate Into Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients
Express News | Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead Ind Candidate Into Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients
Express News | Serina Therapeutics Inc: Today Announced $10 Mln Equity Financing With Strategic Shareholder Juvventures (UK) Limited
Nvidia Discloses New Stake in Applied Digital; Maintains Arm Holdings, SoundHound Stakes
12 Health Care Stocks Moving In Thursday's Pre-Market Session
AgeX Therapeutics GAAP EPS of $0.13, Revenue of $0.01M
Serina Therapeutics 3Q EPS 13c >SER
Serina Therapeutics | 8-K: Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights
Earnings Flash (SER) SERINA THERAPEUTICS Reports Q3 Revenue $14,000
Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights